We also evaluated the expression of RGS20 in our PC cohort, with 40.4% (38/94) of PC cases exhibiting the high RGS20 expression (IHC score ≥ 4) (Figure 1(e), Table 1). This evidence concerns the gene RGS20 and pachyonychia congenita.